Artificial Intelligence

How one company turned its internal training program into a strategic powerhouse, earning a top award and creating a blueprint for the future of work.

At a top Paris expo, GUYU's biotech arm BioQ unveiled cellular anti-aging ingredients, signaling a new era of Chinese innovation in the beauty supply chain.

Online lender Loanz pivots from a tough US market to focus on Canada, deploying AI to serve a growing number of underserved Canadian borrowers.

An innovative RNA-editing therapy for hepatocellular carcinoma has received a major FDA designation, potentially accelerating its path to patients.

A new fund, NICO, challenges ESG norms by investing in tobacco giants, aiming to force a shift to safer products. Can engagement succeed where exclusion has failed?

A three-month FDA delay for a new LEQEMBI injection highlights the high-stakes race for a convenient Alzheimer's therapy and its complex safety hurdles.

A KIST-led delegation of Korean quantum startups partners with IBM, signaling a major push to commercialize deep tech on the global stage.

A Swedish startup is launching a 'participation-first' video app in Brazil, betting that users are tired of passive scrolling. Can it succeed?

The Federation of Thai Industries' support for IME 2026 creates a vital platform for China-Thailand tech exchange, accelerating the region's digital shift.

Avnet's new integration facility in Singapore is more than a building; it's a strategic move in the global shift to diversify tech supply chains beyond China.

Record overseas buyer attendance at the 139th Canton Fair highlights a strategic pivot to high-tech, innovative manufacturing, reshaping global trade.

The healthcare intelligence giant boosts its buyback program, a move analysts see as a bold bet on its own value and a strategic play in a shifting industry.

The service commerce platform saw net income jump over 700% despite a drop in adjusted EBITDA, signaling a massive strategic bet on its AI-driven future.

As complex new global AI and data laws take effect, Canadian businesses are scrambling for guidance, fueling a boom in specialized advisory services.

The cloud company's results show modest growth, but a strategic pivot to shed a recent acquisition and focus on its 'Dash' AI tool is paying off.

With a strong balance sheet and promising data, Enliven Therapeutics is pushing its lead leukemia drug, ELVN-001, into a pivotal late-stage trial.

Semiconductor giant KLA announces a massive stock split and a 21% dividend hike, rewarding shareholders and making its stock more accessible to all.

Artivion posts strong Q1 results and acquires Endospan for its FDA-approved NEXUS system, yet lowers its full-year guidance. What's behind the mixed message?

Job applications have tripled, but your chance of an interview is down 50%. New data reveals how AI is creating a tougher, more selective hiring market.

Carrington acquires Valon Mortgage and adopts its AI platform, a landmark deal set to redefine the complex world of government mortgage servicing.